Hostname: page-component-586b7cd67f-vdxz6 Total loading time: 0 Render date: 2024-11-28T16:57:22.933Z Has data issue: false hasContentIssue false
  • English
  • Français

Friedreich's Ataxia and Oral Glucose Tolerance: II. The effect of ingested glucose on serum growth hormone in homozygotes, obligate heterozygotes and potential carriers of the Friedreich's Ataxia gene

Published online by Cambridge University Press:  18 September 2015

G. Tolis ,
A. Mehta ,
C. Harvey ,
E. Andermann ,
F. Andermann  and
A. Barbeau
G. Tolis
Affiliation:
Royal Victoria Hospital, Montreal and Montreal Neurological Institute; Clinical Research Institute of Montreal
A. Mehta
Affiliation:
Royal Victoria Hospital, Montreal and Montreal Neurological Institute; Clinical Research Institute of Montreal
C. Harvey
Affiliation:
Royal Victoria Hospital, Montreal and Montreal Neurological Institute; Clinical Research Institute of Montreal
E. Andermann
Affiliation:
Royal Victoria Hospital, Montreal and Montreal Neurological Institute; Clinical Research Institute of Montreal
F. Andermann
Affiliation:
Royal Victoria Hospital, Montreal and Montreal Neurological Institute; Clinical Research Institute of Montreal
A. Barbeau*
Affiliation:
Royal Victoria Hospital, Montreal and Montreal Neurological Institute; Clinical Research Institute of Montreal
*
Clinical Research Institute of Montreal, 110 Pine Avenue West, Montreal, Quebec, Canada, H2W 1R7
Rights & Permissions [Opens in a new window]

Summary:

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Homozygotes, obligatory heterozygotes and potential carriers of the Friedreich's Ataxia gene were tested with an oral glucose tolerance in order to assess a. the prevalence of abnormalities in glucose handling, b. the secretory pattern of two “diabetogenic” hormones, growth hormones and prolactin and c. to evaluate the possibility for detection of an abnormal trend in these hormones to be used as a genetic marker. Despite the high prevalence of glucose abnormalities horizontally and vertically in these families, the basal output and responses of these metabolic hormones to a glucose challenge were appropriate and thus not characteristic of any of the above groups.

Type
Quebec Cooperative Study of Friedreich's Ataxia
Information
Canadian Journal of Neurological Sciences , Volume 7 , Issue 4 , November 1980 , pp. 401 - 403
Copyright
Copyright © Canadian Neurological Sciences Federation 1980

References

REFERENCES

Caraceni, T., Panerai, A.E., Parati, A.E., Cocchi, D., and Muller, E.E. (1977). Altered GH and PRL responses to dopaminergic stimulation in Huntington’s chorea. J. Clin. Endocrinol. Metab. 44: 870–875.CrossRefGoogle ScholarPubMed
Collu, R., Geoffroy, G., Melancon, S.B., and Barbeau, A. (1977). Growth hormone levels in Friedreich’s ataxia. Horm. Metab. Res. 9: 523–524.CrossRefGoogle ScholarPubMed
DanowskI,T.S I,T.S. (1975). Classifications of diabetes mellitus in Endocrinology and Diabetes. The Thirtieth Hannenmann Symposium, Kryston, L.J. and Shah, R.A. (eds.), Grune and Stratton Inc. pp. 321–328.Google Scholar
Hwang, P., Guyda, H. and Friesen, H.G. (1971). A radioimmunoassay for human prolactin. Proc. Natl. Acad. Sci. (USA) 68: 1902–1906.CrossRefGoogle ScholarPubMed
Martin, J.B. (1979). Pathophysiology of growth hormone. In Clinical Neuroendo-crinology, Tolis, G.. Labrie, F. Martin, J.B. and Naftolin, F. (eds.) Raven Press, pp. 269–278.Google Scholar
Roth, J.. Glick, S.M., Yalow, R.S.. and Berson, S.A. (1963). Secretion of human growth hormone: Physiologic and experimental modification. Metabolism 12 (7): 577–579.Google ScholarPubMed
Tolis, G. and Franks, S. (1979). Physiology and pathology of prolactin secretion. In Clinical Neuroendocrinology: A pathophysiological approach. Tolis, G.. Labrie, F. Martin, J.B. and Naftolin, F. (eds.) Raven Press, pp. 291–318.Google Scholar